107 related articles for article (PubMed ID: 14982826)
21. Azithromycin for the Treatment of Obliterative Bronchiolitis after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Yadav H; Peters SG; Keogh KA; Hogan WJ; Erwin PJ; West CP; Kennedy CC
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2264-2269. PubMed ID: 27575542
[TBL] [Abstract][Full Text] [Related]
22. Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases?
Brusselle GG
Thorax; 2015 May; 70(5):401-3. PubMed ID: 25870311
[No Abstract] [Full Text] [Related]
23. Home spirometry as early detector of azithromycin refractory bronchiolitis obliterans syndrome in lung transplant recipients.
de Wall C; Sabine D; Gregor W; Mark G; Axel H; Thomas F; Tobias W; Jens G
Respir Med; 2014 Feb; 108(2):405-12. PubMed ID: 24445061
[TBL] [Abstract][Full Text] [Related]
24. Azithromycin in bronchiolitis obliterans: is the evidence strong enough?
Angel LF; Levine D; Sanchez J; Levine S
Am J Respir Crit Care Med; 2006 Feb; 173(4):465-6; author reply 466. PubMed ID: 16467178
[No Abstract] [Full Text] [Related]
25. A case of bronchiolitis obliterans after living-donor renal transplantation.
Hayashi M; Hokari S; Aoki N; Ohshima Y; Watanabe S; Koya T; Tasaki M; Saito K; Kikuchi T
Respir Investig; 2021 May; 59(3):367-371. PubMed ID: 33518470
[TBL] [Abstract][Full Text] [Related]
26. Bronchiolitis obliterans syndrome after lung transplantation: medical treatment.
Verleden GM
Monaldi Arch Chest Dis; 2000 Apr; 55(2):140-5. PubMed ID: 10949876
[TBL] [Abstract][Full Text] [Related]
27. Macrolide antibiotics and bronchiolitis obliterans following lung transplantation.
Crowley S; Egan JJ
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):923-30. PubMed ID: 16307505
[TBL] [Abstract][Full Text] [Related]
28. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study.
Verleden GM; Verleden SE; Vos R; De Vleeschauwer SI; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
Transpl Int; 2011 Jul; 24(7):651-6. PubMed ID: 21401732
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-18: A Novel Participant in the Occurrence, Development, and Drug Therapy of Obliterative Bronchiolitis Postlung Transplantation.
Shu P; Zhang W; Zhang Y; Zhao Y; Li Y; Zhang X
Dis Markers; 2021; 2021():5586312. PubMed ID: 34367377
[TBL] [Abstract][Full Text] [Related]
30. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of total lymphoid irradiation in azithromycin nonresponsive chronic allograft rejection after lung transplantation.
Verleden GM; Lievens Y; Dupont LJ; Van Raemdonck DE; De Vleeschauwer SI; Vos R; Vanaudenaerde BM
Transplant Proc; 2009 Jun; 41(5):1816-20. PubMed ID: 19545735
[TBL] [Abstract][Full Text] [Related]
32. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
Verleden GM; Dupont LJ; Van Raemdonck DE
Eur Respir J; 2005 Feb; 25(2):221-4. PubMed ID: 15684284
[TBL] [Abstract][Full Text] [Related]
33. Clara cell secretory protein and surfactant protein-D do not predict bronchiolitis obliterans syndrome after lung transplantation.
Paantjens AW; Otten HG; van Ginkel WG; van Kessel DA; van den Bosch JM; Kwakkel-van Erp JM; van de Graaf EA
Transplantation; 2010 Aug; 90(3):340-2. PubMed ID: 20683434
[No Abstract] [Full Text] [Related]
34. [Post-lung transplantation bronchiolitis obliterans].
Fournier M; Groussard O; Mal H; Sleiman C; Duchatelle JP; Andreassian B; Pariente R
Rev Mal Respir; 1995; 12(1):5-11. PubMed ID: 7899668
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneity of chronic lung allograft dysfunction: insights from protein expression in broncho alveolar lavage.
Verleden SE; Vos R; Mertens V; Willems-Widyastuti A; De Vleeschauwer SI; Dupont LJ; Verleden GM; Van Raemdonck DE; Vanaudenaerde BM
J Heart Lung Transplant; 2011 Jun; 30(6):667-73. PubMed ID: 21276737
[TBL] [Abstract][Full Text] [Related]
36. [Phenotype profile of blood lymphocytes in bronchiolitis obliterans after lung transplantation].
Fattal-German M; Cerrina J; Le Roy Ladurie F; Berrih-Aknin S
Ann Pharm Fr; 1993; 51(3):125-34. PubMed ID: 8250490
[TBL] [Abstract][Full Text] [Related]
37. Effects of azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT--a randomized double-blinded placebo-controlled study.
Lam DC; Lam B; Wong MK; Lu C; Au WY; Tse EW; Leung AY; Kwong YL; Liang RH; Lam WK; Ip MS; Lie AK
Bone Marrow Transplant; 2011 Dec; 46(12):1551-6. PubMed ID: 21317934
[TBL] [Abstract][Full Text] [Related]
38. Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplant Diagnosed Using Ultrathin Bronchoscopy.
Sato M; Waseda Y; Sonoda T; Tanizawa A; Itoh H; Kobayashi M; Takemura T; Ishizuka T
Am J Respir Crit Care Med; 2022 Jul; 206(1):e1-e3. PubMed ID: 35486846
[No Abstract] [Full Text] [Related]
39. Circumstances of bronchiolitis obliterans development after lung transplantation: analysis of risk factors.
Pereszlenyi A; Harustiak S; Klepetko W
Bratisl Lek Listy; 2000; 101(12):633-8. PubMed ID: 11723655
[TBL] [Abstract][Full Text] [Related]
40. Montelukast for bronchiolitis obliterans syndrome after lung transplantation.
Simons SO; Reijers MH
Chest; 2012 Jan; 141(1):275-276. PubMed ID: 22215841
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
